These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7868750)

  • 1. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma.
    Cerroni L; Kerl H
    J Cutan Pathol; 1994 Oct; 21(5):398-403. PubMed ID: 7868750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers.
    Rodriguez-Villanueva J; Colome MI; Brisbay S; McDonnell TJ
    Pathol Res Pract; 1995 Jun; 191(5):391-8. PubMed ID: 7479356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.
    Verhaegh ME; Sanders CJ; Arends JW; Neumann HA
    Br J Dermatol; 1995 May; 132(5):740-4. PubMed ID: 7772478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi.
    Cerroni L; Soyer HP; Kerl H
    Am J Dermatopathol; 1995 Feb; 17(1):7-11. PubMed ID: 7695015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
    J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
    Branet F; Caron P; Camallières M; Selves J; Brousset P
    Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers.
    Tomková H; Fujimoto W; Arata J
    Eur J Dermatol; 1998 Jun; 8(4):256-60. PubMed ID: 9649682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases.
    Tomková H; Fujimoto W; Arata J
    Br J Dermatol; 1997 Nov; 137(5):703-8. PubMed ID: 9415228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Profile of CD10, BCL-2, p63, and EMA in the Normal Skin and Basal Cell Carcinomas: An Immunohistochemical Reappraisal.
    Hussein MR; Ahmed AM
    Actas Dermosifiliogr; 2022 Oct; 113(9):848-855. PubMed ID: 35636508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocytes in human skin express bcl-2 protein.
    Klein-Parker HA; Warshawski L; Tron VA
    J Cutan Pathol; 1994 Aug; 21(4):297-301. PubMed ID: 7798385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-2 expression in primary malignancies of the skin.
    Morales-Ducret CR; van de Rijn M; LeBrun DP; Smoller BR
    Arch Dermatol; 1995 Aug; 131(8):909-12. PubMed ID: 7632062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. bcl-2 expression in epidermal keratinocytic diseases.
    Nakagawa K; Yamamura K; Maeda S; Ichihashi M
    Cancer; 1994 Sep; 74(6):1720-4. PubMed ID: 8082073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
    Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
    Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation indexes--a comparison between cutaneous basal and squamous cell carcinomas.
    al-Sader MH; Doyle E; Kay EW; Bennett M; Walsh CB; Curran B; Milburn C; Leader M
    J Clin Pathol; 1996 Jul; 49(7):549-51. PubMed ID: 8813951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic changes after photodynamic therapy for Basal cell carcinoma and Bowen disease: a histologic and immunohistochemical investigation.
    Fantini F; Greco A; Cesinaro AM; Surrenti T; Peris K; Vaschieri C; Marconi A; Giannetti A; Pincelli C
    Arch Dermatol; 2008 Feb; 144(2):186-94. PubMed ID: 18283175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
    Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
    Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
    Ritter JH; Dresler CM; Wick MR
    Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.